The past year brought uncertainty and challenges that would have been hard to imagine. We are proud to say that even during this adversity, Friends of Cancer Research expanded our critical work for patients.

Our growing research partnerships represent new collaborative models and are catalyzing science in a way that no single organization could achieve alone. Our policy initiatives are leading to meaningful changes that accelerate the development of new medicines for patients. We do this by bringing together diverse partners — even competitors at times — toward collaborative, science-based solutions and build new models to accelerate cancer research and treatment.

We are proud to share with you our 2020 highlights and the strides we continue to make on behalf of patients and their loved ones. As we review our accomplishments of the past year, and look to the future of what we need to achieve, we would like to thank our Board of Directors, supporters, and partners, without whom our critical work for patients would not be possible.

As we embark on our 25th year, we’re going to keep moving the field forward toward personalized treatments, patient-centered healthcare, and the next generation of breakthrough therapies. We’ll continue to lift up the next generation of scientists and policymakers, and help guide science from idea to reality for patients.